| 000 | 01422 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514000631.0 | ||
| 264 | 0 | _c20010906 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(01)80060-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuay, D R | |
| 245 | 0 | 0 |
_aPharmacokinetics and tolerability of extended-release clarithromycin. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cApr 2001 |
||
| 300 |
_a566-77 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aBronchitis _xdrug therapy |
| 650 | 0 | 4 |
_aClarithromycin _xadministration & dosage |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaxillary Sinusitis _xdrug therapy |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRacial Groups |
| 700 | 1 | _aGustavson, L E | |
| 700 | 1 | _aDevcich, K J | |
| 700 | 1 | _aZhang, J | |
| 700 | 1 | _aCao, G | |
| 700 | 1 | _aOlson, C A | |
| 773 | 0 |
_tClinical therapeutics _gvol. 23 _gno. 4 _gp. 566-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(01)80060-6 _zAvailable from publisher's website |
| 999 |
_c11286639 _d11286639 |
||